The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists

被引:94
作者
Bodur, Cagri [1 ]
Kazyken, Dubek [1 ]
Huang, Kezhen [1 ]
Ustunel, Bilgen Ekim [1 ]
Siroky, Kate A. [1 ]
Tooley, Aaron Seth [1 ]
Gonzalez, Ian E. [1 ]
Foley, Daniel H. [1 ]
Acosta-Jaquez, Hugo A. [1 ]
Barnes, Tammy M. [2 ]
Steinl, Gabrielle K. [2 ]
Cho, Kae-Won [3 ]
Lumeng, Carey N. [3 ]
Riddle, Steven M. [4 ]
Myers, Martin G., Jr. [2 ]
Fingar, Diane C. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA
[4] Illumina, Madison, WI USA
关键词
IFN-beta; mTOR; mTORC1; TBK1; INTERFERON REGULATORY FACTOR-3; BREAST-CANCER ONCOGENE; TRANSLATIONAL CONTROL; ANTIVIRAL IMMUNITY; MAMMALIAN TARGET; CELL-GROWTH; S6; KINASE; SUBSTRATE-SPECIFICITY; MEDIATED ACTIVATION; SIGNAL INTEGRATION;
D O I
10.15252/embj.201696164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The innate immune kinase TBK1 initiates inflammatory responses to combat infectious pathogens by driving production of type I interferons. TBK1 also controls metabolic processes and promotes oncogene-induced cell proliferation and survival. Here, we demonstrate that TBK1 activates mTOR complex 1 (mTORC1) directly. In cultured cells, TBK1 associates with and activates mTORC1 through site-specific mTOR phosphorylation (on S2159) in response to certain growth factor receptors (i.e., EGF-receptor but not insulin receptor) and pathogen recognition receptors (PRRs) (i.e., TLR3; TLR4), revealing a stimulus-selective role for TBK1 in mTORC1 regulation. By studying cultured macrophages and those isolated from genome edited mTOR S2159A knock-in mice, we show that mTOR S2159 phosphorylation promotes mTORC1 signaling, IRF3 nuclear translocation, and IFN-beta production. These data demonstrate a direct mechanistic link between TBK1 and mTORC1 function as well as physiologic significance of the TBK1-mTORC1 axis in control of innate immune function. These data unveil TBK1 as a direct mTORC1 activator and suggest unanticipated roles for mTORC1 downstream of TBK1 in control of innate immunity, tumorigenesis, and disorders linked to chronic inflammation.
引用
收藏
页码:19 / 38
页数:20
相关论文
共 90 条
[1]
Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth [J].
Acosta-Jaquez, Hugo A. ;
Keller, Jennifer A. ;
Foster, Kathryn G. ;
Ekim, Bilgen ;
Soliman, Ghada A. ;
Feener, Edward P. ;
Ballif, Bryan A. ;
Fingar, Diane C. .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (15) :4308-4324
[2]
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production [J].
Alain, Tommy ;
Lun, XueQing ;
Martineau, Yvan ;
Sean, Polen ;
Pulendran, Bali ;
Petroulakis, Emmanuel ;
Zemp, Franz J. ;
Lemay, Chantal G. ;
Roy, Dominic ;
Bell, John C. ;
Thomas, George ;
Kozma, Sara C. ;
Forsyth, Peter A. ;
Costa-Mattioli, Mauro ;
Sonenberg, Nahum .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (04) :1576-1581
[3]
New Insights into mTOR Signaling: mTORC2 and Beyond [J].
Alessi, Dario R. ;
Pearce, Laura R. ;
Garcia-Martinez, Juan M. .
SCIENCE SIGNALING, 2009, 2 (67) :pe27
[4]
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[5]
Integrative genomic approaches identify IKBKE as a breast cancer oncogene [J].
Boehm, Jesse S. ;
Zhao, Jean J. ;
Yao, Jun ;
Kim, So Young ;
Firestein, Ron ;
Dunn, Ian F. ;
Sjostrom, Sarah K. ;
Garraway, Levi A. ;
Weremowicz, Stanislawa ;
Richardson, Andrea L. ;
Greulich, Heidi ;
Stewart, Carly J. ;
Mulvey, Laura A. ;
Shen, Rhine R. ;
Ambrogio, Lauren ;
Hirozane-Kishikawa, Tomoko ;
Hill, David E. ;
Vidal, Marc ;
Meyerson, Matthew ;
Grenier, Jennifer K. ;
Hinkle, Greg ;
Root, David E. ;
Roberts, Thomas M. ;
Lander, Eric S. ;
Polyak, Kornelia ;
Hahn, William C. .
CELL, 2007, 129 (06) :1065-1079
[6]
Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions [J].
Boor, P. P. C. ;
Metselaar, H. J. ;
Mancham, S. ;
van der Laan, L. J. W. ;
Kwekkeboom, J. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 174 (03) :389-401
[7]
CONTROL OF P70 S6 KINASE BY KINASE-ACTIVITY OF FRAP IN-VIVO [J].
BROWN, EJ ;
BEAL, PA ;
KEITH, CT ;
CHEN, J ;
SHIN, TB ;
SCHREIBER, SL .
NATURE, 1995, 377 (6548) :441-446
[8]
Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3) K-mTOR-p70S6K pathway [J].
Cao, Weiping ;
Manicassamy, Santhakumar ;
Tang, Hua ;
Kasturi, Sudhir Pai ;
Pirani, Ali ;
Murthy, Niren ;
Pulendran, Bali .
NATURE IMMUNOLOGY, 2008, 9 (10) :1157-1164
[9]
IDENTIFICATION OF AN 11-KDA FKBP12-RAPAMYCIN-BINDING DOMAIN WITHIN THE 289-KDA FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN AND CHARACTERIZATION OF A CRITICAL SERINE RESIDUE [J].
CHEN, J ;
ZHENG, XF ;
BROWN, EJ ;
SCHREIBER, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4947-4951
[10]
The Protein Kinase IKKε Regulates Energy Balance in Obese Mice [J].
Chiang, Shian-Huey ;
Bazuine, Merlijn ;
Lumeng, Carey N. ;
Geletka, Lynn M. ;
Mowers, Jonathan ;
White, Nicole M. ;
Ma, Jing-Tyan ;
Zhou, Jie ;
Qi, Nathan ;
Westcott, Dan ;
Delproposto, Jennifer B. ;
Blackwell, Timothy S. ;
Yull, Fiona E. ;
Saltiel, Alan R. .
CELL, 2009, 138 (05) :961-975